Amgen Stock Trades Near One-Year High After Strong Q2 Earnings

Amgen's stock price has been holding steady at an elevated level in late August 2026, trading near its one-year high of $447.03. This comes on the heels of the company's impressive second-quarter 2026 results, which saw revenue increase by 9.5% year-over-year to $10.05 billion.

The adjusted earnings per share came in at $6.29, beating market expectations and supported by broad-based growth across Amgen's portfolio.

Investors are taking note of the strong Q2 earnings beat and raised full-year guidance, which now calls for adjusted earnings of $22.30 to $23.50 per share.